PAP Systems External Clinical Studies (ECS)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-130
SponsorResMed

About this trial

This is a pre-market study for ongoing product development aiming to explore the usability and performance of the study PAP systems.

Eligibility criteria

Qualifiers

Participants willing to give written informed consent

Participants who ≥ 18 years of age

Participants being treated for OSA for ≥ 3 months

Participants currently using a suitable PAP system(s)

Disqualifiers

Participants using Bilevel flow generators

Participants who are or may be pregnant

Participants with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury.

Participants believed to be unsuitable for inclusion by the researcher

Trial design

Treatments tested in this trial

  • PAP System A (with Amalfi) then PAP System B (with CLA11)
  • PAP System B (with CLA11) then PAP System A (with Amalfi)

Treatment groups

30 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators